Literature DB >> 10878376

Skin-specific caspase-1-transgenic mice show cutaneous apoptosis and pre-endotoxin shock condition with a high serum level of IL-18.

K Yamanaka1, M Tanaka, H Tsutsui, T S Kupper, K Asahi, H Okamura, K Nakanishi, M Suzuki, N Kayagaki, R A Black, D K Miller, K Nakashima, M Shimizu, H Mizutani.   

Abstract

To study the pathophysiological roles of overexpressed caspase-1 (CASP1), originally designated as IL-1 beta-converting enzyme, we generated transgenic mice in which human CASP1 is overexpressed in their keratinocytes. The transgenic mice spontaneously developed recalcitrant dermatitis and skin ulcers, characterized by the presence of massive keratinocyte apoptosis. The skin of the mice contained the active form of human CASP1 and expressed mRNA for caspase-activated DNase, an effector endonuclease responsible for DNA fragmentation. Their skin and sera showed elevated levels of mature IL-18 and IL-1 beta, but not of IFN-gamma. The plasma from these animals induced IFN-gamma production by IL-18-responsive NK cells. Administration of heat-killed Propionibacterium acnes, a potent in vivo type 1 cell inducer, caused IFN-gamma-mediated lethal liver injury in the transgenic mice, which was completely inhibited by treatment with neutralizing anti-IL-18 Ab. These results indicated that in vivo overexpression of CASP1 caused spontaneous apoptotic tissue injury and rendered mice highly susceptible to exogenous type 1 cell-inducing condition in collaboration with endogenously accumulated proinflammatory cytokines.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10878376     DOI: 10.4049/jimmunol.165.2.997

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

1.  T cells and effector mechanisms in the pathogenesis of atopic dermatitis.

Authors:  Mübeccel Akdis; Axel Trautmann; Kurt Blaser; Cezmi A Akdis
Journal:  Curr Allergy Asthma Rep       Date:  2002-01       Impact factor: 4.806

Review 2.  Lessons from murine models of atopic dermatitis.

Authors:  Tao Zheng; Zhou Zhu
Journal:  Curr Allergy Asthma Rep       Date:  2005-07       Impact factor: 4.806

3.  The interaction between IL-18 and IL-18 receptor limits the magnitude of protective immunity and enhances pathogenic responses following infection with intracellular bacteria.

Authors:  Purnima Ghose; Asim Q Ali; Rong Fang; Digna Forbes; Billy Ballard; Nahed Ismail
Journal:  J Immunol       Date:  2011-06-29       Impact factor: 5.422

Review 4.  Animal models of skin disease for drug discovery.

Authors:  Pinar Avci; Magesh Sadasivam; Asheesh Gupta; Wanessa Cma De Melo; Ying-Ying Huang; Rui Yin; Rakkiyappan Chandran; Raj Kumar; Ayodeji Otufowora; Theodore Nyame; Michael R Hamblin
Journal:  Expert Opin Drug Discov       Date:  2013-01-08       Impact factor: 6.098

Review 5.  Role of interleukin-18 in the pathophysiology of allergic diseases.

Authors:  Nathan L Sanders; Anil Mishra
Journal:  Cytokine Growth Factor Rev       Date:  2016-07-15       Impact factor: 7.638

6.  Role of caspase 1 in murine antibacterial host defenses and lethal endotoxemia.

Authors:  Vishwas D Joshi; Dhananjaya V Kalvakolanu; John R Hebel; Jeffrey D Hasday; Alan S Cross
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

7.  Staphlyococcus aureus phenol-soluble modulins stimulate the release of proinflammatory cytokines from keratinocytes and are required for induction of skin inflammation.

Authors:  Adnan K Syed; Tamra J Reed; Kaitlyn L Clark; Blaise R Boles; J Michelle Kahlenberg
Journal:  Infect Immun       Date:  2015-06-15       Impact factor: 3.441

8.  Cross-regulation between LUBAC and caspase-1 modulates cell death and inflammation.

Authors:  Todd Douglas; Maya Saleh
Journal:  J Biol Chem       Date:  2020-03-02       Impact factor: 5.157

Review 9.  Animal models of atopic dermatitis.

Authors:  Haoli Jin; Rui He; Michiko Oyoshi; Raif S Geha
Journal:  J Invest Dermatol       Date:  2009-01       Impact factor: 8.551

Review 10.  Mast cells in atopic dermatitis.

Authors:  Toshiaki Kawakami; Tomoaki Ando; Miho Kimura; Bridget S Wilson; Yuko Kawakami
Journal:  Curr Opin Immunol       Date:  2009-10-14       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.